VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
Genfit’s Acquisition of Versantis
Genfit’s Licensing Agreement with Genoscience Pharma
Goodwin Procter advised Genfit on the deal. Genfit entered into a licensing agreement with Genoscience Pharma for exclusive right to develop and commercialize the investigational treatment...